RESUMEN
OBJECTIVE: Early diffuse scleroderma (systemic sclerosis; SSc) has no proven treatment. This study was undertaken to examine the efficacy of methotrexate (MTX) in improving the skin and other disease parameters in early diffuse SSc. METHODS: Seventy-one patients with diffuse SSc of <3 years' duration were enrolled in a multicenter, randomized, placebo-controlled, double-blind trial. Thirty-five patients were treated with MTX and 36 with placebo. Treatment was administered for 12 months. The primary outcome measures were skin score (as determined with 2 different indices) and physician global assessment. RESULTS: At baseline, there were no statistically significant differences in skin scores, carbon monoxide diffusing capacity (DLco), physician global assessment, or other secondary outcome measurements between the 2 treatment groups. At study completion, results slightly favored the MTX group (mean +/- SEM modified Rodnan skin score 21.4+/-2.8 in the MTX group versus 26.3+/-2.1 in the placebo group [P < 0.17]; UCLA skin score 8.8+/-1.2 in the MTX group versus 11.0+/-0.9 in the placebo group [P < 0.15]; DLco in the MTX group 75.7+/-4.6 versus 61.8+/-3.4 in the placebo group [P < 0.2]). In addition, physician global assessment results favored MTX (P < 0.035), whereas patient global assessment did not differ significantly between groups. When between-group differences for changes in scores from baseline to 12 months were examined using intent-to-treat methodology, MTX appeared to have a favorable effect on skin scores (modified Rodnan score -4.3 in the MTX group versus 1.8 in the placebo group [P < 0.009]; UCLA score -1.2 in the MTX group versus 1.2 in the placebo group [P < 0.02]), but differences in the degree of change in the DLco and physician global assessment were not significant. For the UCLA skin score, these differences in results were not statistically significant after adjustment for baseline differences in sex distribution and steroid use. Dropout rates were similar in the 2 groups. CONCLUSION: Although results of this trial demonstrated a trend in favor of MTX versus placebo in the treatment of early diffuse SSc, the between-group differences were small and the power to rule out false-negative results was only 50%. Our findings do not provide evidence that MTX is significantly effective in the treatment of early diffuse SSc.
Asunto(s)
Inmunosupresores/uso terapéutico , Metotrexato/uso terapéutico , Esclerodermia Sistémica/tratamiento farmacológico , Evaluación de la Discapacidad , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Estado de Salud , Humanos , Masculino , Persona de Mediana Edad , Esclerodermia Sistémica/patología , Índice de Severidad de la Enfermedad , Piel/efectos de los fármacos , Piel/patología , Encuestas y Cuestionarios , Resultado del TratamientoAsunto(s)
Artritis/complicaciones , Congelación de Extremidades/complicaciones , Deformidades Adquiridas de la Mano/etiología , Esclerodermia Localizada/complicaciones , Síndrome de Sjögren/complicaciones , Adulto , Artritis/diagnóstico por imagen , Artritis/patología , Frío , Femenino , Congelación de Extremidades/patología , Deformidades Adquiridas de la Mano/diagnóstico por imagen , Deformidades Adquiridas de la Mano/patología , Humanos , Masculino , Persona de Mediana Edad , Radiografía , Esclerodermia Localizada/patología , Síndrome de Sjögren/patologíaRESUMEN
OBJECTIVE: To determine the HLA associations of seropositive rheumatoid arthritis (RA) in a Cree and Ojibway population; to determine whether specific alleles distinguish juvenile or adult onset. METHODS: HLA-A, B, C, and DRB1 alleles were analyzed in 23 Ojibway and Cree patients with RA seen in a single tertiary care center. Comparisons were made with published results of controls and with results of 18 patients with rheumatoid factor (RF) positive polyarticular juvenile rheumatoid arthritis (JRA) from the same population. RESULTS: Comparisons among patients with RA, patients with RF positive polyarticular JRA, and controls showed increased frequencies of the RA shared epitope in patients with RA and of DRB1*0901 in patients with seropositive polyarticular JRA, while the frequency of DRB1*08 alleles was decreased in patients with RF positive polyarticular JRA. CONCLUSION: In this population, DRB1*0901 may promote while DRB1*08 alleles may protect against a juvenile onset of RA specifically. In contrast, the RA shared epitope may have a greater effect on the risk of adult onset seropositive RA. Due to the small patient numbers, these results require confirmation.
Asunto(s)
Artritis Reumatoide/genética , Antígenos HLA/genética , Indígenas Norteamericanos/genética , Adulto , Anciano , Alelos , Artritis Reumatoide/sangre , Artritis Reumatoide/epidemiología , Canadá/epidemiología , Estudios de Casos y Controles , Frecuencia de los Genes , Antígenos HLA-A/genética , Antígenos HLA-B/genética , Antígenos HLA-DR/genética , Cadenas HLA-DRB1 , Prueba de Histocompatibilidad , Humanos , Persona de Mediana EdadRESUMEN
Umbilical cord blood (CB) transplantation is thought to be associated with a reduced risk of severe graft-versus-host-disease (GVHD) compared with bone marrow transplantation (BMT). The cytokine cascade is known to be important in the pathogenesis of GVHD; however, previous studies investigating the cytokine secretion pattern of CB cells have been contradictory because of variations in experimental techniques. In this study, the cytokine profile of cord and adult blood lymphocytes and lymphocyte subsets has been assessed at the single-cell level by flow cytometry, using CD4/CD8 and CD45RA/CD45RO markers. Cord and adult blood mononuclear cells were stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin in the presence of monensin. After 4 to 24 hours of incubation, interleukin-2 (IL-2), IL-4, interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha) production was measured by three-color flow cytometry. The results show that cord blood lymphocytes (CBL) produce less IL-2, IL-4, IFN-gamma, and TNF-alpha than adult peripheral blood lymphocytes (ABL). Further subset analysis showed that in CBL the majority of cytokine producing cells were CD4(+)CD45RA+, whereas in ABL the cytokine-producing cells were both CD4(+)CD45RO+ and CD8(+)CD45RO+. These results suggest that the reduced incidence of GVHD in CB transplantation may partly due to the altered cytokine profile seen in CBL.
Asunto(s)
Citocinas/inmunología , Sangre Fetal/inmunología , Linfocitos/inmunología , Adulto , Antígenos CD/inmunología , Citocinas/análisis , Citometría de Flujo , Enfermedad Injerto contra Huésped/inmunología , Humanos , Inmunofenotipificación , Subgrupos de Linfocitos T/inmunologíaRESUMEN
Current evidence indicates that the neuroendocrine system is the highest regulator of immune/inflammatory reactions. Prolactin and growth hormone stimulate the production of leukocytes, including lymphocytes, and maintain immunocompetence. The hypothalamus-pituitary-adrenal axis constitutes the most powerful circuit regulating the immune system. The neuropeptides constituting this axis, namely corticotrophin releasing factor, adrenocorticotrophic hormone, alpha-melanocyte stimulating hormone, and beta-endorphin are powerful immunoregulators, which have a direct regulatory effect on lymphoid cells, regulating immune reactions by the stimulation of immunoregulatory hormones (glucocorticoids) and also by acting on the central nervous system which in turn generates immunoregulatory nerve impulses. Peptidergic nerves are major regulators of the inflammatory response. Substance P and calcitonin gene-related peptide are pro-inflammatory mediators and somatostatin is anti-inflammatory. The neuroendocrine regulation of the inflammatory response is of major significance from the point of view of immune homeostasis. Malfunction of this circuit leads to disease and often is life-threatening. The immune system emits signals towards the neuroendocrine system by cytokine mediators which reach significant blood levels (cytokine-hormones) during systemic immune/inflammatory reactions. Interleukin-1, -6, and TNF-alpha are the major cytokine hormones mediating the acute phase response. These cytokines induce profound neuroendocrine and metabolic changes by interacting with the central nervous system and with many other organs and tissues in the body. Corticotrophin releasing factor functions under these conditions as a major co-ordinator of the response and is responsible for activating the ACTH-adrenal axis for regulating fever and for other CNS effects leading to a sympathetic outflow. Increased ACTH secretion leads to glucocorticoid production. alpha-melanocyte stimulating hormone functions under these conditions as a cytokine antagonist and an anti-pyretic hormone. The sympathetic outflow, in conjunction with increased adrenal activity. leads to the elevation of catecholamines in the bloodstream and in tissues. Current evidence suggests that neuroimmune mechanisms are essential in normal physiology, such as tissue turnover, involution, atrophy, intestinal function, and reproduction. Host defence against infection, trauma and shock relies heavily on the neuroimmunoregulatory network. Moreover, abnormalities of neuroimmunoregulation contribute to the aetiology of autoimmune disease, chronic inflammatory disease, immunodeficiency, allergy, and asthma. Finally, neuroimmune mechanisms play an important role in regeneration and healing.
Asunto(s)
Sistema Inmunológico/fisiología , Neuropéptidos/fisiología , Animales , Formación de Anticuerpos , Humanos , Sistema Hipotálamo-Hipofisario/fisiología , Sistema Hipófiso-Suprarrenal/fisiología , Prolactina/fisiologíaRESUMEN
A 35-year-old man with idiopathic eosinophilic fasciitis (EF) and morphea developed renal disease characterized by microscopic hematuria, nephrotic range proteinuria, and rapidly progressing hypertension, an association that has not previously been reported in EF. Initial clinical symptoms of EF began in July 1989; peripheral eosinophilia peaked at 30% in August 1990; an abnormal urinalysis was first observed in March 1992 and subsequently a renal biopsy was performed. Renal biopsy demonstrated focal segmental glomerulosclerosis and a subepithelial immune-type deposit. Partial fasciectomy and a course of methotrexate resulted in overall functional improvement of his extremities. Proteinuria and hematuria was reduced during methotrexate therapy.
Asunto(s)
Fascitis/tratamiento farmacológico , Hipergammaglobulinemia/tratamiento farmacológico , Inmunoglobulina M , Enfermedades Renales/tratamiento farmacológico , Metotrexato/uso terapéutico , Esclerodermia Localizada/tratamiento farmacológico , Adulto , Eosinofilia/tratamiento farmacológico , Eosinofilia/patología , Eosinofilia/cirugía , Fascitis/patología , Fascitis/cirugía , Humanos , Enfermedades Renales/patología , MasculinoRESUMEN
We describe three patients, all of them lower limb amputees who also had seropositive, nodular rheumatoid arthritis. In each case, rheumatoid nodules developed on the amputation stump, causing difficulties with prosthesis fit and comfort and impairment of ambulation. Nodules were successfully excised in two cases and the prosthesis modified in the third. The patients were able to resume walking or transferring with their prostheses.
Asunto(s)
Muñones de Amputación , Artritis Reumatoide/complicaciones , Nódulo Reumatoide/complicaciones , Anciano , Miembros Artificiales , Femenino , Humanos , Pierna , Masculino , Persona de Mediana Edad , Ajuste de Prótesis , Nódulo Reumatoide/cirugíaRESUMEN
Recent studies indicate that pituitary hormones play an important role in immunoregulation. The evidence that endocrine abnormalities are associated with, and may contribute to the development of autoimmune disease is reviewed and discussed. Patients suffering from rheumatoid arthritis show a number of endocrine abnormalities that indicate altered pituitary function. The decreased bioactivity of prolactin and possible inadequate glucocorticoid response to inflammation found in patients may have an etiological role in rheumatoid arthritis. The further clarification of the possible role of endocrine factors in the etiology of autoimmune disease is needed urgently.
Asunto(s)
Artritis Reumatoide/etiología , Autoinmunidad/fisiología , Hormonas/fisiología , Autotolerancia/fisiología , Retroalimentación/fisiología , Humanos , Sistemas Neurosecretores/fisiología , Sistema Hipófiso-SuprarrenalRESUMEN
Prolactin and growth hormone were determined from the sera of 48 patients with rheumatoid arthritis (RA) and 23 controls by radioimmunoassay and by the Nb2 lymphoma proliferation bioassay. A highly significant deficiency was found in the bioactivity of circulating prolactin (PRL) in patients with RA, whereas immunoactive PRL was near normal. Only age matched male patients showed significantly lower serum PRL levels by radioimmunoassay. Patients with RA with anemia and high reticulocyte counts had bioactivity of PRL elevated and those with anemia and low reticulocyte counts had a decreased bioactivity of PRL when compared to patients without anemia. Prolactin isolated from the sera of 5 patients with RA showed decreased bioactivity in comparison with PRL separated from 5 sex matched controls. Serum factors capable of enhancing or inhibiting the response of Nb2 cells to ovine PRL were also discovered. Our results indicate that RA is associated with PRL deficiency.
Asunto(s)
Artritis Reumatoide/sangre , Prolactina/deficiencia , Anemia/sangre , Anemia/complicaciones , Animales , Artritis Reumatoide/complicaciones , Artritis Reumatoide/patología , Bioensayo , Recuento de Células Sanguíneas , División Celular/efectos de los fármacos , Femenino , Humanos , Masculino , Prolactina/farmacología , Radioinmunoensayo , Reticulocitos/patología , Ovinos , Células Tumorales Cultivadas/patologíaRESUMEN
Response to sulfasalazine was studied for 1 year in 45 patients with rheumatoid arthritis. Twenty-two patients achieved a satisfactory clinical response. Adverse reactions developed in 15. Hemoglobin rose, and platelet count, erythrocyte sedimentation rate, rheumatoid factor titer, immunoglobulins, and C3 component of complement fell in relation to degree of response. At 1 year, 18 patients elected to continue the treatment. No relationship between clinical response, adverse reactions, or laboratory changes and drug disposition was observed.
Asunto(s)
Artritis Reumatoide/tratamiento farmacológico , Sulfasalazina/uso terapéutico , Acetilación , Adulto , Anciano , Anticuerpos/inmunología , Artritis Reumatoide/sangre , Artritis Reumatoide/epidemiología , Artritis Reumatoide/patología , Ensayos Clínicos como Asunto , Proteínas del Sistema Complemento/análisis , ADN/inmunología , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Inmunoglobulinas/análisis , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Prospectivos , Sulfasalazina/efectos adversos , Sulfasalazina/sangreRESUMEN
Two siblings, a 38-year-old woman and a 33-year-old man, developed eosinophilic fasciitis within a period of 6 months. They were found to have identical HLA-A, B, DR, and DQ antigens, raising the possibility of a genetic influence in the development of this disease. No common environmental factors close to the time of onset were identified; however, the possibility of a common, remote environmental factor cannot be discounted.
Asunto(s)
Eosinofilia/genética , Fascitis/genética , Adulto , Biopsia , Eosinofilia/metabolismo , Familia , Fascitis/metabolismo , Femenino , Antígenos HLA/metabolismo , Humanos , MasculinoAsunto(s)
Periodicidad , Sinovitis/complicaciones , Tiroiditis Autoinmune/complicaciones , Adolescente , Adulto , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Prevalence and incidence rates for rheumatic diseases were found to be minimal among the Inuit people in the Keewatin District of the Northwest Territories, Canada. Patient identification was achieved by a review of medical records. All identified patients were interviewed and examined by a participating rheumatologist. Among women, the prevalence of rheumatoid arthritis, adjusted for age of the Manitoba population, was 1,822 per 100,000 and was comparable with that observed in other populations; no cases of rheumatoid arthritis in men were confirmed. The age-adjusted prevalence of osteoarthritis, 1,219 per 100,000 in men and 2,144 per 100,000 in women, was apparently low. A moderately high incidence of Reiter's syndrome, 24.9 per 100,000, was found. The findings in children suggested a high frequency of seronegative spondylarthropathies (yearly incidence 60.1 per 100,000), although the adjusted yearly incidence for juvenile rheumatoid arthritis also appeared to be high, 23.6 per 100,000. The frequencies of HLA antigens in patient groups were compared with those found in 19 patients with musculoskeletal complaints but no rheumatic disease. Both HLA-B27 and HLA-DR4 appeared to be common in these controls, 36.8% and 63.2%, respectively. Nevertheless, there was a higher frequency of HLA-B27 in patients with seronegative spondylarthropathies (87%) than in controls (P = 0.001). Because of the small numbers of patients who had rheumatoid arthritis, no associations with HLA were made for this condition. Although the findings suggest differences in the distribution of rheumatic diseases compared with those found in other populations, more complete studies are required to confirm these observations.
Asunto(s)
Indígenas Norteamericanos , Enfermedades Reumáticas/epidemiología , Adulto , Artritis/epidemiología , Artritis/inmunología , Artritis Juvenil/epidemiología , Artritis Juvenil/inmunología , Artritis Reumatoide/epidemiología , Artritis Reumatoide/inmunología , Niño , Femenino , Antígenos HLA/análisis , Antígenos HLA/clasificación , Humanos , Masculino , Persona de Mediana Edad , Osteoartritis/epidemiología , Osteoartritis/inmunología , Enfermedades Reumáticas/clasificación , Enfermedades Reumáticas/inmunología , Serología , Enfermedades de la Columna Vertebral/epidemiología , Enfermedades de la Columna Vertebral/inmunologíaRESUMEN
Thirty-one patients with chronic active rheumatoid arthritis (RA) resistant to gold and/or penicillamine therapy, were treated with sulfasalazine, 2-3 g daily, in a 12-week open study. Nineteen patients completed the study, and of these, 13 showed clinical improvement. Twelve patients were withdrawn from the study because of nausea (8), mouth ulcers (1), disease flare (1) and noncompliance (2). There was no significant difference in serum sulfasalazine concentrations among responders, nonresponders and patients who were withdrawn. Our data suggest that sulfasalazine may be of benefit in the treatment of RA. Further studies are necessary to determine if toxicity and/or efficacy might be related to serum concentrations of sulfasalazine metabolites.
Asunto(s)
Artritis Reumatoide/tratamiento farmacológico , Sulfasalazina/uso terapéutico , Adulto , Anciano , Artritis Reumatoide/sangre , Artritis Reumatoide/fisiopatología , Sedimentación Sanguínea , Ensayos Clínicos como Asunto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Sulfasalazina/efectos adversos , Sulfasalazina/sangreRESUMEN
Measurements of maximum respiratory pressures and routine pulmonary function tests were performed in 8 patients with polymyositis (PM) and 2 patients with dermatomyositis (DM). Serial measurements of routine pulmonary function tests in 8 patients remained unchanged. Maximum respiratory pressures were decreased initially in 7 patients with proximal muscle weakness and clinically active muscle disease and improved with corticosteroid therapy in the 5 patients who were followed serially. In 3 patients with clinically stable disease the maximum respiratory muscle power was normal. Serial measurements of maximum respiratory pressures have been of value in monitoring patients with PM and DM.
Asunto(s)
Dermatomiositis/fisiopatología , Miositis/fisiopatología , Sistema Respiratorio/fisiopatología , Adulto , Anciano , Femenino , Volumen Espiratorio Forzado , Humanos , Masculino , Persona de Mediana Edad , Músculos/fisiopatología , Presión , Volumen Residual , Capacidad Pulmonar Total , Capacidad VitalRESUMEN
Equilibration of salicylic, salicyluric and gentisic acids between plasma and synovial fluid (SF) was measured in 36 patients receiving chronic salicylate therapy and from whom SF was required for diagnostic purposes. Gentisic and salicyluric acids equilibrated completely, while SF salicylic acid concentration was less than that in plasma. The presence of significant gentisic acid concentrations in SF could contribute to the therapeutic response to chronic salicylate therapy, since its antiinflammatory effect is even greater than that of acetylsalicylic acid.